title: Platelet-derived growth factor-BB supports the survival of cultured rat Schwann cell precursors in synergy with neurotrophin-3.
abstract: To understand the intimate axon-Schwann cell relationship required for the accurate development and regeneration of the peripheral nervous system (PNS), it is important to elucidate the repertoire of growth factors involved in this tightly regulated bi-directional dialogue. We focused on the identification and functional characterization of receptor tyrosine kinases (RTKs) in Schwann cells to gain insights into the corresponding growth factor ligands, which may be regulating the highly controlled differentiation of the Schwann cell lineage. Using an RT-PCR based differential display approach, we have identified 17 tyrosine kinases in embryonic rat sciatic nerves during the crucial transition from Schwann cell precursors to early Schwann cells. In this study, we have examined the expression and function of TrkC and the platelet-derived growth factor (PDGF) receptors alpha and beta on Schwann cell precursor cells. These receptors are expressed on freshly isolated Schwann cell precursors, and we show that PDGF-BB is able to rescue a subpopulation of these cells from apoptotic cell death in vitro. Furthermore, the TrkC-ligand neurotrophin-3 (NT-3) can act synergistically to potentiate this effect. However, PDGF-BB and NT-3 do not induce Schwann cell precursor proliferation or differentiation. Our data are consistent with a model suggesting that a combination of growth factors that include PDGF-BB and NT-3 are acting in concert and in synergy to regulate early Schwann cell development.
authors.affiliation: Institute of Cell Biology, Swiss Federal Institute of Technology, Zurich, Switzerland.
authors.forename: C S
authors.initials: CS
authors.lastname: Lobsiger
authors.forename: B
authors.initials: B
authors.lastname: Schweitzer
authors.forename: V
authors.initials: V
authors.lastname: Taylor
authors.forename: U
authors.initials: U
authors.lastname: Suter
mesh_terms: D000818:Animals; D000077214:Becaplermin; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology; D002454:Cell Differentiation; D002478:Cells, Cultured; D004622:Embryo, Mammalian; D020933:Neurotrophin 3 / Q000378:metabolism*; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D020574:Proto-Oncogene Proteins c-sis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011919:Rats, Inbred Strains; D020800:Receptor, Nerve Growth Factor / Q000032:analysis; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics; D020812:Receptor, trkC / Q000235:genetics; D012583:Schwann Cells / Q000187:drug effects* / Q000378:metabolism*; D013234:Stem Cells / Q000187:drug effects* / Q000378:metabolism*; D013997:Time Factors
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D020933:Neurotrophin 3; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D012333:RNA, Messenger; D020800:Receptor, Nerve Growth Factor; D000077214:Becaplermin; D011505:Protein-Tyrosine Kinases; D020796:Receptor, Platelet-Derived Growth Factor alpha; D020797:Receptor, Platelet-Derived Growth Factor beta; D020812:Receptor, trkC